JP2011528700A5 - - Google Patents

Download PDF

Info

Publication number
JP2011528700A5
JP2011528700A5 JP2011519181A JP2011519181A JP2011528700A5 JP 2011528700 A5 JP2011528700 A5 JP 2011528700A5 JP 2011519181 A JP2011519181 A JP 2011519181A JP 2011519181 A JP2011519181 A JP 2011519181A JP 2011528700 A5 JP2011528700 A5 JP 2011528700A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
penetration enhancer
monoalcohol
humectant
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011519181A
Other languages
English (en)
Japanese (ja)
Other versions
JP5667052B2 (ja
JP2011528700A (ja
Filing date
Publication date
Priority claimed from EP08305421A external-priority patent/EP2147674A1/en
Application filed filed Critical
Publication of JP2011528700A publication Critical patent/JP2011528700A/ja
Publication of JP2011528700A5 publication Critical patent/JP2011528700A5/ja
Application granted granted Critical
Publication of JP5667052B2 publication Critical patent/JP5667052B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011519181A 2008-07-24 2009-07-24 ダナゾールを含む経真皮医薬組成物 Active JP5667052B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12986108P 2008-07-24 2008-07-24
EP08305421.3 2008-07-24
EP08305421A EP2147674A1 (en) 2008-07-24 2008-07-24 Transdermal pharmaceutical compositions comprising danazol
US61/129,861 2008-07-24
PCT/EP2009/059538 WO2010010168A1 (en) 2008-07-24 2009-07-24 Transdermal pharmaceutical compositions comprising danazol

Publications (3)

Publication Number Publication Date
JP2011528700A JP2011528700A (ja) 2011-11-24
JP2011528700A5 true JP2011528700A5 (cg-RX-API-DMAC10.html) 2012-09-06
JP5667052B2 JP5667052B2 (ja) 2015-02-12

Family

ID=39926759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011519181A Active JP5667052B2 (ja) 2008-07-24 2009-07-24 ダナゾールを含む経真皮医薬組成物

Country Status (7)

Country Link
US (1) US20110118226A1 (cg-RX-API-DMAC10.html)
EP (2) EP2147674A1 (cg-RX-API-DMAC10.html)
JP (1) JP5667052B2 (cg-RX-API-DMAC10.html)
AU (1) AU2009273211B2 (cg-RX-API-DMAC10.html)
CA (1) CA2731501C (cg-RX-API-DMAC10.html)
ES (1) ES2533854T3 (cg-RX-API-DMAC10.html)
WO (1) WO2010010168A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
US20180169117A1 (en) * 2014-03-20 2018-06-21 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical formulation comprising a substituted phenyl - (1,3-dihydro-isoindol-2-yl) - methanone
US10872313B2 (en) 2015-06-02 2020-12-22 ROCA Medical Ltd. Method for repurposing NDC codes in a pharmaceutical database for venom derived allergens involved in venom immunotherapy
US10548974B2 (en) 2015-06-02 2020-02-04 ROCA Medical Ltd. Therapeutic treatment kit for allergies based on DNA profiles
US10369215B2 (en) 2015-06-02 2019-08-06 ROCA Medical Ltd. Predilution sets for distributing antigens
PL3934624T3 (pl) * 2019-12-09 2024-07-08 Futura Medical Developments Limited Kompozycja do stosowania miejscowego i sposoby pomiaru zdolności chłodzącej kompozycji do stosowania miejscowego

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007A (en) * 1845-04-22 Improvement in separating tannin and coloring-matter in quercitron-bark
US8015A (en) * 1851-04-01 Connecting and disconnecting wheels and axles
BE531437A (cg-RX-API-DMAC10.html) * 1953-08-26
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
FR2718372B1 (fr) 1994-04-08 1996-06-28 Sofab Dispensateur de produits fluides.
FR2723356B1 (fr) 1994-08-08 1996-10-18 Innovation Rech Plastique Sa Dispositif de conditionnement d'un produit avec pompe manuelle de distribution en doses unitaires
FR2726810B1 (fr) 1994-11-10 1997-01-31 Soc D Promotion Rech Et Innova Pompe doseuse a commande manuelle pour flacon a enveloppe deformable
WO2000072883A2 (en) * 1999-06-02 2000-12-07 Aviana Biopharm Pharmaceutical transdermal compositions
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
KR20030048021A (ko) * 2000-08-30 2003-06-18 유니메드 파마슈티칼스, 인크. 여성의 테스토스테론 및 관련된 스테로이드의 농도를증가시키는 방법
WO2002087543A1 (en) * 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
AU2006207868A1 (en) * 2002-03-20 2006-09-28 Alkermes, Inc. Method and apparatus for producing dry particles
FR2848112B1 (fr) * 2002-12-10 2007-02-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations
US7812010B2 (en) 2003-01-02 2010-10-12 Femmepharma, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
CA2519980C (en) * 2003-04-01 2012-04-10 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
US7879357B2 (en) * 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
US7132680B2 (en) * 2003-06-09 2006-11-07 International Business Machines Corporation Organic field-effect transistor and method of making same based on polymerizable self-assembled monolayers
CA2433101A1 (en) * 2003-06-23 2004-12-23 Igor Gonda Method of treatment of a female suffering from androgen insufficiency
CA2538856C (en) * 2003-10-10 2010-06-29 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
JP2008512425A (ja) * 2004-09-09 2008-04-24 ラボラトワール ブザン アンテルナスィヨナル 透過促進剤としてのプロピレングリコールを含むテストステロンゲル
EP1634583A1 (en) * 2004-09-09 2006-03-15 Laboratoires Besins International Testosterone gels comprising propylene glycol as penetration enhancer
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
WO2008059060A1 (en) * 2006-11-17 2008-05-22 Besins Healthcare Liquid pharmaceutical compositions comprising a bisphosphonate compound
EP2104489A2 (en) * 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topical administration of danazol
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents

Similar Documents

Publication Publication Date Title
EP2931324B1 (en) Compositions and methods for tissue regeneration
JP2009280627A5 (cg-RX-API-DMAC10.html)
JP2013511534A5 (cg-RX-API-DMAC10.html)
CN101972225A (zh) 一种含吡非尼酮的凝胶组合物
JP2011500597A5 (cg-RX-API-DMAC10.html)
CN102085176A (zh) 一种纳米级伊曲康唑外用制剂、其制备方法及其用途
ES2624557T3 (es) Composiciones farmacéuticas transdérmicas que comprenden un SERM
CN102641299A (zh) 一种痔疮外用药物组合物
WO2011127829A1 (zh) 纳米碳颗粒作为治疗痔疮的外用药物的应用
CN102218074A (zh) 一种含有芍药苷和甘草次酸的透皮贴剂及其制备方法
WO2016177269A1 (zh) 一种治疗和/或预防男性型脱发的复方外用药
CN101455654B (zh) 精氨酸布洛芬凝胶剂及其制备方法
CN101810597A (zh) 一种含马钱子碱的透皮贴剂及其制备方法和其应用
ES2533854T3 (es) Composiciones farmacéuticas transdérmicas que comprenden danazol
CN104138350A (zh) 一种黄芩素温敏凝胶及其制备方法和应用
JP2013163681A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
EP4716539A1 (en) Pharmaceutical composition
JP5699184B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
CN102370947B (zh) 具有消炎、止痒和消毒杀菌功效的外用制剂及其制备方法
JP2006501303A (ja) ニトロキシド放射線防護製剤および使用法
CN102049050B (zh) 抗疱疹病毒感染的药物组合物
ES2376865T3 (es) Tratamiento y prevención de la cicatrización excesiva
RU2586043C1 (ru) Способ профилактики и лечения осложнений при лучевой терапии рака кожи
CN102552916B (zh) 水杨酸钠的新用途
CN105769859B (zh) 一种治疗宫颈癌患者放疗后皮肤损伤的药物组合物及其应用